1293981-99-3

Upstream product

• 34693-28-2 (3aR,6aS)-2,2-dimethyl-3a,6a-dihydrofuro[2,3-d][1,3]dioxol-6(5H)-one 
• 33962-36-6 1,2-O-isopropylidene-3-vinyl-α-D-erythrofuranose 
• 1293981-98-2 1,2-O-isopropylidene-(E)-3-(diethylphosphono)allyl-α-D-erythrofuranose 
• 98-88-4 benzoyl chloride 
• 34693-27-1 (3aR,6S,6aR)-6-hydroxy-tetrahydro-2,2-dimethylfuro[2,3-d][1,3]dioxole 

Downstream Products

• 1293982-05-4 1,2,3-O-tribenzoyl-3-(diethylphosphono)propyl-D-erythrofuranose 
• 1293982-06-5 1-(N6-benzoyladenin-9-yl)-2,3-O-dibenzoyl-3-(diethylphosphono)propyl-β-D-erythrofuranose 
• 1293982-07-6 1-(thymin-1-yl)-2,3-O-dibenzoyl-3-(diethylphosphono)-propyl-β-D-erythrofuranose 
• 1293982-01-0 1-(N6-benzoyladenin-9-yl)-2,3-O-dibenzoyl-(E)-3-(diethylphosphono)allyl-β-D-erythrofuranose 
• 1293982-02-1 1-(thymin-1-yl)-2,3-O-dibenzoyl-(E)-3-(diethylphosphono)allyl-β-D-erythrofuranose 

Relevant academic research and scientific papers

Synthesis of (E)-3′-phosphonoalkenyl modified nucleoside phosphonates via a highly stereoselective olefin cross-metathesis reaction

The synthesis of (E)-3′-phosphonoalkenyl and 3′-phosphonoalkyl modified nucleoside analogues with a β-d-erythrofuranose moiety is reported. The highly stereoselective olefin cross-metathesis reaction was applied to introduce the phosphonoalkenyl group at